NMN 500 by Purely Beneficial — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size

30 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Nicotinamide Mononucleotide

500 mg

📊 Market median: 250.0mg (1 products) 📚 6 studies (Tier A: 0, B: 2)

This product: 500mg

Other Ingredients

Methylcellulose Capsule

Label Claims — Verification

❓ All Other

❓ Structure/Function

All Other (100% of products) Structure/Function (90% of products) Nutrient (2% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: Take two (2) capsules with full glass of water, one or two (1-2) times per day, or as directed by a physician.

⚠️ Warnings & Precautions

Caution: Do not exceed recommended dose.

Pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement.

🧪 Formulation Notes

Vegan

Nicotinamide mononucleotide

Pure & powerful

Does not contain: Fillers, artifiical ingredients, GMO, preservatives, soy, gluten, dairy, gelatin, flavoring, coloring.

Additional Information

Made in the USA with global ingredients

GMP Good Manufacturing Practice Consistent Quality

Manufactured at an FDA registered facility

100% satisfaction guaranteed

Product Details

UPC / SKU 8 60004 19291 6

DSLD Entry Date 2022-11-22

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand Purely Beneficial

DSLD ID 276539

Data Updated 2026-04-11

Research Evidence

8 Research Sources

54 Avg Quality Score

4 Rct

2 Meta Analysis

2 Clinical Trial

B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials

Meta Analysis Critical reviews in food science and nutrition 2025

PubMed DOI

B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study

Rct GeroScience 2024

PubMed DOI

C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.

Rct Science (New York, N.Y.)

PubMed DOI

C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.

Rct GeroScience

PubMed DOI

C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials

Meta Analysis Current diabetes reports 2024

PubMed DOI

C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial

Rct Scientific reports 2023

PubMed DOI

C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.

Clinical Trial ClinicalTrials.gov 2021

ClinicalTrials.gov

C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function

Clinical Trial ClinicalTrials.gov 2017

ClinicalTrials.gov

View all evidence for Nmn →